drugset / Trial / NCT07496450
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of age.
Timeline
- Start
- 2026-03-23
- Primary completion
- 2027-01-28
- Completion
- 2027-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mRNA-1018-H5 | Unknown | — | Intramuscular |